Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Oct;102(1):11–16. doi: 10.1111/j.1365-2249.1995.tb06629.x

HCV infection in patients with primary defects of immunoglobulin production.

I Quinti 1, F Pandolfi 1, R Paganelli 1, D el Salman 1, A Giovannetti 1, R Rosso 1, A Oliva 1, L Rainaldi 1, F Aiuti 1
PMCID: PMC1553328  PMID: 7554376

Abstract

We tested for infection with hepatitis C virus (HCV) in 58 patients affected by humoral immunodeficiencies: 43 common variable immunodeficiency (CVI), two hyper IgM syndrome (HIM), two IgG subclass deficiency, four ataxia-telangiectasia (AT), and seven X-linked agammaglobulinaemia (XLA). While the assessment of serum specific HCV antibodies in some of these patients was not informative because of the impairment in specific antibody production, the reverse transcriptase polymerase chain reaction (RT-PCR) assay used to detect serum HCV RNA was a useful method for diagnosing infection. We found that 38% of late onset hypogammaglobulinaemic patients (CVI, HIM or IgG subclass deficiency) had evidence of HCV infection. HCV infection was not detectable in patients with XLA or AT. The majority of our patients had persistent viraemia, and those who underwent liver biopsy showed histological findings of chronic hepatitis. Moreover, we could demonstrate in vitro that eight of 18 HCV-infected patients were actively producing anti-HCV antibodies, despite their impaired antibody production. The high rate of HCV infection in hypogammaglobulinaemic patients could be related to several nosocomial routes of transmission, including intravenous immune globulin administration. Despite the persistent viremia only two patients had cirrhosis and none had hepatocarcinoma.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 1992 Sep 19;340(8821):697–698. doi: 10.1016/0140-6736(92)92234-7. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  3. Björkander J., Cunningham-Rundles C., Lundin P., Olsson R., Söderström R., Hanson L. A. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988 Jan;84(1):107–111. doi: 10.1016/0002-9343(88)90016-2. [DOI] [PubMed] [Google Scholar]
  4. Bjøro K., Frøland S. S., Yun Z., Samdal H. H., Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. 1994 Dec 15;331(24):1607–1611. doi: 10.1056/NEJM199412153312402. [DOI] [PubMed] [Google Scholar]
  5. Bukh J., Purcell R. H., Miller R. H. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):187–191. doi: 10.1073/pnas.89.1.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chiaramonte M., Stroffolini T., Caporaso N., Coppola R., Craxì A., Gaeta G. B., Sagnelli E., Zanetti A. R. Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol. 1991 Dec;23(9):555–558. [PubMed] [Google Scholar]
  7. Choi Y. S., Biggar W. D., Good R. A. Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia. Lancet. 1972 May 27;1(7761):1149–1152. doi: 10.1016/s0140-6736(72)91374-8. [DOI] [PubMed] [Google Scholar]
  8. De Santis A., Paganelli R., Stefanoni R., Di Sabatino A., Angelico M. Prevalence of gallstones in patients with primary immunoglobulin deficiency. Evidence for lack of association. Dig Dis Sci. 1990 Jun;35(6):716–720. doi: 10.1007/BF01540173. [DOI] [PubMed] [Google Scholar]
  9. Döcke W. D., Simon H. U., Fietze E., Prösch S., Diener C., Reinke P., Stein H., Volk H. D. Cytomegalovirus infection and common variable immunodeficiency. Lancet. 1991 Dec 21;338(8782-8783):1597–1597. doi: 10.1016/0140-6736(91)92422-x. [DOI] [PubMed] [Google Scholar]
  10. Esteban J. I., González A., Hernández J. M., Viladomiu L., Sánchez C., López-Talavera J. C., Lucea D., Martin-Vega C., Vidal X., Esteban R. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med. 1990 Oct 18;323(16):1107–1112. doi: 10.1056/NEJM199010183231605. [DOI] [PubMed] [Google Scholar]
  11. Farci P., Alter H. J., Wong D., Miller R. H., Shih J. W., Jett B., Purcell R. H. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med. 1991 Jul 11;325(2):98–104. doi: 10.1056/NEJM199107113250205. [DOI] [PubMed] [Google Scholar]
  12. François M., Dubois F., Brand D., Bacq Y., Guerois C., Mouchet C., Tichet J., Goudeau A., Barin F. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol. 1993 May;31(5):1189–1193. doi: 10.1128/jcm.31.5.1189-1193.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greenberger P. A., Walker C. L., Fitzsimons T. E., Roberts M. Hypogammaglobulinemia associated with cytomegalovirus pneumonia. J Infect Dis. 1991 Mar;163(3):631–633. doi: 10.1093/infdis/163.3.631. [DOI] [PubMed] [Google Scholar]
  14. Hosoda K., Omata M., Yokosuka O., Kato N., Ohto M. Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver. Hepatology. 1992 May;15(5):777–781. doi: 10.1002/hep.1840150506. [DOI] [PubMed] [Google Scholar]
  15. Lane R. S. Non-A, non-B hepatitis from intravenous immunoglobulin. Lancet. 1983 Oct 22;2(8356):974–975. doi: 10.1016/s0140-6736(83)90496-8. [DOI] [PubMed] [Google Scholar]
  16. Lefrère J. J., Mariotti M., Trepo C., Li J. S., Lunel F., Frangeul L., Letourneur F., Laporte J. P., Jullien A. M. Testing for HCV-RNA in commercial intravenous immunoglobulins. Lancet. 1993 Mar 27;341(8848):834–835. doi: 10.1016/0140-6736(93)90615-n. [DOI] [PubMed] [Google Scholar]
  17. Minor P., Pipkin P., Thorpe R., Thomas D. Antibody to hepatitis C virus in plasma pools. Lancet. 1990 Jul 21;336(8708):188–188. doi: 10.1016/0140-6736(90)91719-q. [DOI] [PubMed] [Google Scholar]
  18. Non-A, non-B hepatitis and intravenous immunoglobulin. Lancet. 1985 Feb 16;1(8425):404–405. [PubMed] [Google Scholar]
  19. Quinti I., Paganelli R., Scala E., Guerra E., Mezzaroma I., D'Offizi G. P., Aiuti F. Hepatitis C virus antibodies in gammaglobulin. Lancet. 1990 Dec 1;336(8727):1377–1377. doi: 10.1016/0140-6736(90)92927-a. [DOI] [PubMed] [Google Scholar]
  20. Quinti I., Sacco G., el Salman D., Paganelli R., Fiorilli M., Aiuti F., Pandolfi F. Infection with hepatitis C virus. Intravenous gammaglobulin may still infect patients. BMJ. 1994 Mar 26;308(6932):856–856. doi: 10.1136/bmj.308.6932.856a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Saldanha J., Minor P. A sensitive PCR method for detecting HCV RNA in plasma pools, blood products, and single donations. J Med Virol. 1994 May;43(1):72–76. doi: 10.1002/jmv.1890430114. [DOI] [PubMed] [Google Scholar]
  22. Saxon A., Sidell N., Zhang K. B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation. Cell Immunol. 1992 Oct 1;144(1):169–181. doi: 10.1016/0008-8749(92)90234-g. [DOI] [PubMed] [Google Scholar]
  23. Soothill J. F., Hayes K., Dudgeon J. A. The immunoglobulins in congenital rubella. Lancet. 1966 Jun 25;1(7452):1385–1388. doi: 10.1016/s0140-6736(66)90299-6. [DOI] [PubMed] [Google Scholar]
  24. Stuyver L., Rossau R., Wyseur A., Duhamel M., Vanderborght B., Van Heuverswyn H., Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993 Jun;74(Pt 6):1093–1102. doi: 10.1099/0022-1317-74-6-1093. [DOI] [PubMed] [Google Scholar]
  25. Tosato G., Magrath I., Koski I., Dooley N., Blaese M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med. 1979 Nov 22;301(21):1133–1137. doi: 10.1056/NEJM197911223012101. [DOI] [PubMed] [Google Scholar]
  26. Yu M. Y., Mason B. L., Tankersley D. L. Detection and characterization of hepatitis C virus RNA in immune globulins. Transfusion. 1994 Jul;34(7):596–602. doi: 10.1046/j.1537-2995.1994.34794330014.x. [DOI] [PubMed] [Google Scholar]
  27. Zielen S., Bauscher P., Hofmann D., Meuer S. C. Interleukin 10 and immune restoration in common variable immunodeficiency. Lancet. 1993 Sep 18;342(8873):750–751. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES